CRP Quantitative Testing Reagent
Vietnam·Risk Class TTBYT Loại B·CRPHS·Roche Diagnostics GmbH·Registered Jan 18, 2023- Analysis ID
- 230000139/PCBB-HCM
- Submission ID
- 000.00.19.H29-230113-0008
- Product Type
- CRPHS
- Product Code
- 04628918190
- Manufacturer
- Roche Diagnostics GmbH
- Intended Use
- In vitro testing is used to quantify the C-reactive protein (CRP) in human serum and plasma on various systems, including the Roche/Hitachi cobas c. The CRP measurement is used to detect and assess various inflammatory disorders and related diseases, infections, and tissue damage. High-sensitivity CRP measurements can also be used to support the evaluation of the risk of coronary artery disease in the future. When used to support other diagnostic methods in the coronary artery disease syndrome, it can also be an independent prognostic indicator of recurrent events in stable coronary artery disease patients or in the coronary artery disease syndrome.
- Registration Date
- Jan 18, 2023
Companies providing products similar to "CRP Quantitative Testing Reagent"
Recently registered similar products
Access comprehensive regulatory information for CRP Quantitative Testing Reagent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230000139/PCBB-HCM and manufactured by Roche Diagnostics GmbH.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Roche Diagnostics GmbH, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.